Mark For: FUSION BIOVENTURE™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 97276885 |
Mark Literal Elements | FUSION BIOVENTURE |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | NEW APPLICATION PROCESSING 2022-02-24 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Perry Gattegno |
2020-09-00 | Date of First Use |
2020-09-01 | Date of First Use |
2020-09-01 | Date of Use In Commerce |
2022-02-21 | Application Filed |
2022-02-24 | Location: NEW APPLICATION PROCESSING |
2022-02-24 | Status: Live/Pending |
2022-02-24 | Status: New application will be assigned to an examining attorney approximately 6 months after filing date. |
2022-02-24 | Transaction Date |
Party: | ![]() |
Address | 91 Hartwell Avenue Lexington, MASSACHUSETTS UNITED STATES 02421 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | 2022-02-21 | |
![]() | 2022-02-21 | |
![]() | 2022-02-21 |
IC 036. US 100 101 102. G & S: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies. FIRST USE: 20200900. FIRST USE IN COMMERCE: 20200900
IC 042. US 100 101. G & S: Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development. FIRST USE: 20200900. FIRST USE IN COMMERCE: 20200900
International Codes: | 36 |
U.S. Codes: | 100,101,102 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0361 | Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies |
GS0361 | Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-02-24 | |
NEW APPLICATION ENTERED IN TRAM | 2022-02-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.